Journal List > J Korean Med Sci > v.35(40) > 1146185

Bahk, Kim, Park, Min, Kim, and Ha: Incidence and Risk Factors of Gastrointestinal and Hepatobiliary Complications after Spinal Fusion Surgery: a Retrospective Cohort Study

Abstract

Background

Spinal surgery holds a higher chance of unpredicted postoperative medical complications among orthopedic surgeries. Several studies have analyzed the risk factors for diverse postoperative medical complications, but the majority investigated incidences of each complication qualitatively. Among gastrointestinal complications, reports regarding postoperative ileus were relatively frequent. However, risk factors or incidences of hepatobiliary complications have yet to be investigated. The purpose of this study was to examine the incidence of gastrointestinal complications after spinal surgery, quantitatively analyze the risk factors of frequent complications, and to determine cues requiring early approaches.

Methods

In total, 234 consecutive patients who underwent spinal fusion surgery performed by one senior doctor at our institute in one-year period were retrospectively enrolled for analyses. The primary outcomes were presence of paralytic ileus, elevated serum alanine transaminase (ALT) and aspartate transaminase (AST) levels, and elevated total bilirubin levels. Univariate logistic regression analyses of all variables were performed. In turn, significant results were reanalyzed by multivariate logistic regression. The variables used were adjusted with age and gender.

Results

Gastrointestinal complications were observed in 15.8% of patients. Upon the risk factors of postoperative ileus, duration of anesthesia (odds ratio [OR], 1.373; P = 0.015), number of fused segments (OR, 1.202; P = 0.047), and hepatobiliary diseases (OR, 2.976; P = 0.029) were significantly different. For elevated liver enzymes, men (OR, 2.717; P = 0.003), number of fused segments (OR, 1.234; P = 0.033), and underlying hepatobiliary (OR, 2.704; P = 0.031) and rheumatoid diseases (OR, 5.021; P = 0.012) had significantly different results. Lastly, risk factors for total bilirubin elevation were: duration of anesthesia (OR, 1.431; P = 0.008), number of fused segments (OR, 1.359; P = 0.001), underlying hepatobiliary diseases (OR, 3.426; P = 0.014), and thoracolumbar junction involving fusions (OR, 4.134; P = 0.002) compared to lumbar spine limited fusions.

Conclusion

Patients on postoperative care after spinal surgery should receive direct attention as soon as possible after manifesting abdominal symptoms. Laboratory and radiologic results must be carefully reviewed, and early consultation to gastroenterologists or general surgeons is recommended to avoid preventable complications.

Graphical Abstract

jkms-35-e345-abf001.jpg

INTRODUCTION

Spinal surgery tends to be more aggressive and has higher risk than other orthopedic surgeries because it is sensitively related to the neurologic entity and tends to require a longer operation time. Therefore, unpredicted postoperative medical complications often lead to problems, which requires keen awareness. Common gastrointestinal complications after spinal surgery are postoperative ileus, constipation, and fecal impaction with rare complications of acute appendicitis, ascites, colitis, gastrointestinal bleeding, and bowel perforation. Several studies have analyzed the risk factors leading to diverse medical complications after spinal surgery, but most of them looked into incidences of each complication qualitatively, reporting the incidence of gastrointestinal complications ranging from 0.1% to 8.6%.12345 Among them, reports regarding symptomatic postoperative ileus were relatively frequent, with 2.6%–13.4% incidence after undergoing all spinal procedures, which represented the smallest value in posterior approaches.678
On the other hand, risk factors or incidences of hepatobiliary complications have yet to be investigated. Serum liver enzymes and total bilirubin levels are checked routinely in postoperative care, as they are often temporarily elevated, though they may be associated with the development of hepatitis, pancreatitis, or acute cholecystitis.910 Case reports of acute cholecystitis and hepatitis after spinal surgery have previously been reported, but qualitative analysis of associated laboratory testing is yet to be conducted.1112 Gastrointestinal complications are generally detected and diagnosed through patients' symptoms, whereas elevated serum markers of hepatobiliary complications are often asymptomatic and thought to be temporary, and therefore easily overlooked.
In reviewing our institute's data, presentations of postoperative ileus were frequently observed after spinal fusion surgeries; the results were as expected, but there were also two startling cases of periappendiceal abscess and acute cholecystitis leading to subsequent urgent surgical intervention. The aim of this study is to examine the incidence of gastrointestinal complications after spinal surgery, quantitatively analyze the risk factors of frequent complications, and determine cues requiring early approaches.

METHODS

In total, 234 consecutive patients who underwent spine surgery performed by one senior doctor at our institute from January 1st, 2017 to December 31th, 2017 were retrospectively enrolled in the registry with institutional review board approval from the Institutional Review Board. Posterior and direct lateral spinal fusion surgeries on the thoracolumbar and the lumbar spines were included. All operations were performed in prone position under general endotracheal anesthesia. However, lateral decubitus position was performed for direct lateral lumbar interbody fusion (DLIF), followed by consecutive posterolateral interbody fusion (PLIF) in prone position. Eventually, all surgeries were performed in prone position.
The enrolled indications in this study were: 1) posterior instrumentation with or without DLIF and 2) thoracolumbar or lumbar spinal fusion. The excluded indications were: 1) cervical and thoracic fusion only, 2) anterior interbody fusion through a trans-peritoneal approach, 3) spine surgery without posterior instrumented fusion such as diskectomy and laminectomy, and 4) fractures and tumors with neurological complications.
The patients' data were reviewed on the medical charts by a spine fellow and a resident. The following demographic and surgical data were analyzed: age, gender, levels of fused segments, location of fusion (lumbar spine limited, thoracolumbar junction involving, or thoracic spine limited), surgical approaches (posterior, direct lateral, or both), ASA (American Society of Anesthesiologists) physical status classification, and duration of general anesthesia (in hours).
The primary outcomes were presence of paralytic ileus, elevated serum alanine transaminase (ALT) and aspartate transaminase (AST) levels, and elevated total bilirubin levels. The diagnosis of paralytic ileus was confirmed by gastroenterologists under consultation and radiologist's formal reading for plain abdomen radiographs. Liver function tests and total bilirubin levels were investigated. Laboratory results were routinely checked on postoperative day as well as the following day, and these were compared with preoperative data. Serum levels of > 40 unit per liter for ALT, > 45 unit per liter for AST, and > 1.58 mg/dL for total bilirubin levels were considered as elevation according to our institute's diagnostic reference. More than > X2 upper limit of normal levels of ALTs or ASTs were considered to be significant, indicating that further diagnostic evaluation including imaging studies is necessary,13 whereas > X1 upper limit of normal level was considered to be significant for the total bilirubin.
The underlying diseases of patients were identified by reviewing the anesthesiologist's preoperative assessment charts: the categories were subdivided into hypertension, diabetes mellitus, gastrointestinal, hepatobiliary, endocrinology, rheumatology, and cancer. In addition, diseases were quantified according to the updated Charlson's comorbidity index scoring system.141516
Univariate logistic regression analyses of all variables were performed for all 234 patients who met the criteria. In turn, significant results were reanalyzed by multivariate logistic regression. The variables used were adjusted with age and gender. P values lower than 0.05 were considered as significant, and all statistical analyses were conducted using R version 3.5.1.

Ethics statement

This study was approved by the Institutional Review Board of the Catholic Medical Center (approval No. KC19RESI0394). Informed consent was waived by the board.

RESULTS

Demographics

In total, 234 patients (282 surgeries) met the inclusion criteria; they had an average age of 65.9 ± 13.0 years, and average of 246.6 ± 83.2 minutes of general endotracheal anesthesia, and 150 of the patients were (62.5%) women. 181 cases (77.4%) of discretely lumbar spine involving fusions and 196 (83.8%) cases of posterior lumbar interbody fusions (PLIFs) were predominantly performed (Table 1). Gastrointestinal complications presented with clinical symptoms were observed in 15.8% of patients (37/234) with diagnoses including paralytic ileus, fecal impactions, periappendiceal abscess, acute cholecystitis, common hepatic duct dilatation, and some non-diagnostic abdominal pain (Figs. 1 and 2). One patient with postoperatively elevated total bilirubin manifested physical examinations of surgical abdomen, was thus diagnosed with acute cholecystitis and underwent laparoscopic cholecystectomy. In another case, periappendiceal abscess was diagnosed on the 12th postoperative day, and this was treated with pigtail drainage.
Table 1

Group demographics of all 234 patients who underwent spinal fusion surgery

jkms-35-e345-i001
Parameters Values
Average age, yr 65.9 ± 13.0
Women, % 62.5
Duration of anesthesia, min 246.6 ± 83.2
ASA 1.95 ± 0.4
No. of segments fused 2.76 ± 1.89
Level of fusion
Limited to lumbar spine 181 (77.4)
Involves thoracolumbar junction 34 (14.5)
Limited to thoracic spine 19 (8.12)
Surgical approach
Posterolateral interbody fusion 196 (83.8)
Direct lateral interbody fusion 22 (9.4)
Combined fusion 16 (6.8)
Underlying diseases
Hypertension 111 (47.0)
Diabetes mellitus 57 (24.4)
Cancer 36 (15.4)
Endocrinology 28 (12.0)
Hepatobiliary 25 (10.7)
Rheumatology 11 (4.7)
Gastrointestinal 8 (3.4)
Charlson's comorbidity index 2.86 ± 1.69
Values are presented as mean ± standard deviation or number (%).
ASA = American Society of Anesthesiology.
Fig. 1

Presented symptoms of gastrointestinal complications after spinal fusion. Abdominal pain (48%) was the predominant symptom perceived by the patients.

jkms-35-e345-g001
Fig. 2

Diagnosed gastrointestinal and hepatobiliary complications of 31 (13.2%) cases after spinal fusion out of the total 234 patients. Paralytic ileus (52%) was observed most frequently. Indeed, the asymptomatic feature in the majority of cases of serum hepatobiliary marker elevations should be taken into account.

CHD = common hepatic duct.
jkms-35-e345-g002

Total gastrointestinal complications and postoperative ileus

Univariate logistic regression analyses for all gastrointestinal complications revealed that underlying hepatobiliary diseases (OR, 4.345; P = 0.030) were a risk factor while age, sex, surgical approaches, number of segments, fusion types, and fusion levels were not. Upon the incidence of postoperative ileus, duration of anesthesia (OR, 1.373; P = 0.015), number of fused segments (OR, 1.202; P = 0.047), underlying diabetes mellitus (OR, 0.278; P = 0.029), and underlying hepatobiliary diseases (OR, 2.976; P = 0.029) were significantly different, while the surgical approaches and level of fusion were not. Interestingly, in contrast to our common understanding, diabetes mellitus was shown to be inversely correlated with the incidence of postoperative ileus (Table 2). Multiple logistic regression analysis confirmed that underlying diabetes (OR, 0.279; P = 0.042) and hepatobiliary diseases (OR, 2.704; P = 0.031) were risk factors of postoperative ileus.
Table 2

Univariate logistic regression analysis for postoperative paralytic ileus after spinal fusion

jkms-35-e345-i002
Items OR 95% CI P value
Age 1.012 0.983–1.049 0.458
Gender, women:men 1.432 0.645–3.428 0.394
Duration of anesthesia, hr 1.373 1.001–1.010 0.015*
ASA 0.806 0.682–0.282 0.682
No. of fused segments 1.202 0.047–0.996 0.047*
Charlson's comorbidity index 1.007 0.962–0.736 0.962
Underlying diseases
Hypertension 0.598 0.260–1.332 0.213
Diabetes mellitus 0.278 0.064–0.831 0.042*
Gastrointestinal < 0.001 N/A 0.986
Hepatobiliary 2.976 1.060–7.692 0.029*
Endocrinology 1.433 0.440–3.987 0.515
Rheumatology 0.541 0.029–2.958 0.564
Cancer 1.127 0.357–2.992 0.822
Surgical approach
PLIF vs. DLIF 1.510 0.403–4.599 0.497
PLIF vs. PLIF & DLIF 2.427 0.635–7.695 0.153
DLIF vs. PLIF & DLIF 1.607 0.320–8.137 0.555
Level of fusion
L-spine vs. T-L junction 1.328 0.459–3.367 0.571
L-spine vs. T-spine < 0.001 0.000–0.000 0.986
T-L junction vs. T-spine < 0.001 0.000–0.000 0.986
*P < 0.05.

Elevated liver enzymes

Postoperative liver enzyme level elevation was observed in 63 (26.9%) patients. Gender (women to men: OR, 0.508; P = 0.024), duration of anesthesia (OR, 1.298; P = 0.017), number of fused segments (OR, 1.270; P = 0.002), underlying hepatobiliary diseases (OR, 2.630; P = 0.029), and underlying rheumatologic diseases (OR, 4.632; P = 0.013) showed significant effects (Table 3). In addition, multivariate analysis revealed that men (OR, 2.717; P = 0.003), number of fused segments (OR, 1.234; P = 0.033), and underlying hepatobiliary (OR, 2.704; P = 0.031) and rheumatoid diseases (OR, 5.021; P = 0.012) were also main risk factors.
Table 3

Univariate logistic regression analysis of postoperative serum liver function test elevation (> 80 units/liter for alanine transaminase, > 90 units/liter for aspartate transaminase) after spinal fusion

jkms-35-e345-i003
Items OR 95% CI P value
Age 1.002 0.980–1.026 0.860
Gender, women:men 0.508 0.281–0.917 0.024*
Duration of anesthesia, hr 1.298 1.048–1.614 0.017*
ASA 0.753 0.332–1.644 0.485
No. of fused segments 1.270 1.092–1.486 0.002**
Charlson's comorbidity index 1.080 0.873–1.320 0.455
Underlying diseases
Hypertension 0.817 0.437–1.520 0.524
Diabetes mellitus 0.650 0.304–1.312 0.245
Gastrointestinal 2.819 0.636–12.510 0.158
Hepatobiliary 2.630 1.087–6.268 0.029*
Endocrinology 1.094 0.142–1.420 0.236
Rheumatology 4.632 1.391–16.587 0.013*
Cancer 1.094 0.478–2.369 0.824
Surgical approach
PLIF vs. DLIF 1.066 0.359–2.827 0.902
PLIF vs. PLIF & DLIF 0.375 0.057–1.420 0.208
DLIF vs. PLIF & DLIF 0.352 0.046–1.854 0.248
Level of fusion
L-spine vs. T-L junction 0.991 0.409–2.232 0.982
L-spine vs. T-spine 0.644 0.172–1.942 0.466
T-L junction vs. T-spine 0.650 0.149–2.467 0.539
*P < 0.05; **P < 0.01.

Elevated total bilirubin

Similarly, postoperative total bilirubin level elevation was observed in 29 (12.4%) patients. Significantly increased risks were associated with the duration of anesthesia (OR, 1.431; P = 0.008), number of fused segments (OR, 1.359; P = 0.001), underlying hepatobiliary diseases (OR, 3.426; P = 0.014), and thoracolumbar junction involving fusions (OR, 4.134; P = 0.002) compared to lumbar spine limited fusions (Table 4).
Table 4

Univariate logistic regression analysis of postoperative serum total bilirubin level (1.58 mg/dL) after spinal fusion

jkms-35-e345-i004
Items OR 95% CI P value
Age 0.997 0.971–1.029 0.868
Gender, women:men 0.767 0.349–1.729 0.512
Duration of anesthesia, hr 1.431 1.097–1.875 0.008**
ASA 2.446 0.923–6.690 0.072
No. of fused segments 1.359 1.133–1.637 0.001*
Charlson's comorbidity index 1.144 0.875–1.444 0.278
Underlying diseases
Hypertension 0.865 0.373–1.988 0.731
Diabetes mellitus 0.322 0.074–0.968 0.073
Gastrointestinal 1.008 0.053–6.003 0.994
Hepatobiliary 3.426 1.213–8.957 0.014*
Endocrinology 0.244 0.013–1.253 0.178
Rheumatology 0.650 0.035–3.573 0.686
Cancer 1.873 0.683–4.660 0.194
Surgical approach
PLIF vs. DLIF 1.149 0.252–3.815 0.836
PLIF vs. PLIF & DLIF 0.465 0.025–2.463 0.468
DLIF vs. PLIF & DLIF 0.405 0.019–3.565 0.455
Level of fusion
L-spine vs. T-L junction 4.134 1.648–10.083 0.002**
L-spine vs. T-spine 1.068 0.157–4.324 0.935
T-L junction vs. T-spine 0.258 0.036–1.182 0.113
*P < 0.05; **P < 0.01.
In addition, it took averages of 1.8 days and 6.3 days for serum total bilirubin levels and liver enzyme levels to reach their peak levels, respectively.

DISCUSSION

Among medical complications, gastrointestinal and hepatobiliary complications are considered to be relatively less common, but they can still lead to life-threatening conditions.1 In this study, among apparent gastrointestinal and hepatobiliary complications after spinal fusion (13.2%), paralytic ileus (6.8%) and fecal impaction (3.4%) were the most frequently observed for gastrointestinal complications, with no cases of gastrointestinal bleeding, emphasizing its significance in managing paralytic ileus. Regarding hepatobiliary complications, overt liver enzyme elevation was present in roughly one-fourth (26.9%) of total cases, and in about one-eighth (12.4%) for total bilirubin elevation (Tables 1 and 2). The complications were not significantly different according to age, gender, approaches, surgical approaches, location of fusion, or Charlson's comorbidity index. Several studies have reported the incidences of paralytic ileus after spinal fusion surgery. A cohort study of 220,522 lumbar fusions revealed 3.5% total incidence of postoperative paralytic ileus,17 with 2.6% after posterior lumbar fusions (PLFs) and 7.5% after anterior lumbar fusions (ALFs). Earlier studies reported a higher incidence of 14.8% in 121 ALFs.18
The mechanism of postoperative ileus is mainly functional (paralytic), which is a reversible disturbance manifesting from the third to fifth day after surgery that frequently presents as abdominal pain, nausea, vomiting, abdominal distension, or constipation (fecal impaction).19 In our study, 22 patients out of 31 diagnosed complications (71%) complained of abdominal pain (Table 1). Gastrointestinal tract motility may be reduced, leading to paralytic ileus partly by surgery, partly by the residual effects of anesthetic agents, and particularly by opioids administered for postoperative pain relief.20 An additionally suggested mechanism is that spinal manipulations including mid to lower thoracic levels or upper lumbar levels might provoke and damage splanchnic nerves, resulting in decreased gastrointestinal motility and reactive ileus.2 On the other hand, avoiding early oral intake after surgery is known to be a simple prevention strategy for the postoperative ileus.3 Treatments for postoperative ileus include nothing per os (NPO), application of nasogastric tubes, early enteral nutrition, early mobilization, administration of metoclopramide, cisapride, opiate antagonist, laxatives, and even nonsteroidal anti-inflammatory drugs.21
Older age, men, and circumferential fusion compared to discrete anterior or posterior approaches for fusion have been reported to be risk factors for ileus.17 Moreover, total estimated blood loss and total opiate dosage have also been reported as risk factors.22 Postoperative pain control in our study was mostly achieved by patient controlled analgesia (PCA) composed of fentanyl and ramosetron, with additional per re nata tramadol or pethidine injections for postoperative pain control. Opioids are well known to induce bowel dysfunction by the activation of mu-opioid receptors in the gastrointestinal tract.23
Univariate logistic regression analyses revealed that duration of anesthesia, number of segments fused, and hepatobiliary complications are risk factors of postoperative paralytic ileus, while age, gender, and circumferential approaches are not. A doubtful result of reduced risks in underlying diabetes mellitus (OR, 0.278; P = 0.042) was also confirmed by multivariate logistic regression analysis (Table 5), contradicting our previously held knowledge regarding increased oxidative stress in diabetic patients which leads to decreased bowel motility.17242526 The result might suggest a false negative, indicating the need for further analysis with a larger sized study. However, the associated contingency table shows that only three of 57 diabetic patients developed postoperative ileus, while 28 were present among 177 non-diabetic patients. Considering that the sample size is not too small, the possibility of an unexplained mechanism still exists.
Table 5

Multiple logistic regression for risk factors with significant result from univariate logistic regression analysis for each outcomes

jkms-35-e345-i005
Items OR 95% CI P value
Postoperative ileus
Duration of anesthesia, hr 1.324 0.963–1.828 0.082
No. of fused segments 1.063 0.839–1.332 0.601
Diabetes mellitus 0.279 0.063–0.859 0.042*
Hepatobiliary diseases 3.045 1.034–8.330 0.034*
Elevated liver enzymes
Gender, women:men 0.368 0.188–0.704 0.003**
Duration of anesthesia, hr 1.112 0.843–1.465 0.448
No. of fused segments 1.234 1.018–1.503 0.033*
Hepatobiliary diseases 2.704 1.077–6.700 0.031*
Rheumatoid diseases 5.021 1.434–18.916 0.012*
Elevated total bilirubin levels
Duration of anesthesia, hr 1.103 0.772–1.565 0.581
No. of fused segments 1.253 0.962–1.626 0.089
Level of fusion, L-spine vs. T-L junction 2.899 0.989–8.240 0.051
*P < 0.05; **P < 0.01.
For postoperatively elevated liver enzymes, multivariate logistic regression revealed that men, number of fused segments, underlying hepatobiliary diseases, and rheumatoid diseases were risk factors (Table 5). Hepatobiliary diseases would certainly accelerate the rise, but a notable result of rheumatoid diseases is accounted for by the relatively excess load of hepatotoxic medications used for the treatment. The only risk factor identified of postoperatively elevated serum total bilirubin levels after multiple logistic regression was fusions involving thoracolumbar junctions (Table 5). A mechanism that may be suggested for the latter is manipulation of splanchnic nerves from celiac plexus arising from lower thoracic levels affecting the metabolism of hepatobiliary functions.
Abdominal pain after spinal surgery is a popular subject demanding doctor's attention for patients on postoperative care. In majority of cases, the symptoms can be easily relieved by simple prescriptions or conservative management, or they are spontaneously regressed by an unknown mechanism. However, the indifference and ignorance of the doctor in charge might lead to a crisis, as they could have had various chances to prevent issues.
Gastrointestinal and hepatobiliary complications can be prevented in number of ways, but it cannot be fully prevented, since surgical interventions under general anesthesia have inevitable consequences themselves. Disease entities which will later develop into a condition requiring immediate interventions are hidden in between the majority of naturally or easily subsiding symptoms. Hence, even a simple abdominal pain must not be neglected. Basic approaches of careful physical examinations, plain abdominal radiograph, follow-up blood tests, and early CT scans in doubtful conditions accompanied by inter-department consultations will lead to providential cut off devastating consequences. Thus, the most predisposing factor of developing comorbidities might be the carefulness and keen awareness of the treating physician.
This study was limited to patients who complained of abdominal pain that developed during one year after spine surgery. However, the findings of this study suggest a new level of importance in scrutinizing the methods involved in evaluating patients who complain of abdominal pain and avoiding the dismissal of pain that may initially seem trivial. The reason for such limitation was that the preliminary results have clearly shown the possibility of developing pain in this short time frame, and the results between this study and those with longer time frames were statistically insignificant. In addition, the two patients that described the development of serious pain in a short time frame further undermined the need for a larger sample size, even though these occurrences were very rare.
In conclusion, patients on postoperative care after spinal surgery should receive direct attention as soon as possible after manifesting abdominal symptoms. Laboratory and radiologic results must be carefully reviewed, and early consultation to gastroenterologists or general surgeons is recommended to avoid preventable complications.

Notes

Disclosure: The authors have no potential conflicts of interest to disclose.

Author Contributions:

  • Conceptualization: Ha KY.

  • Data curation: Bahk JH.

  • Formal analysis: Min HK.

  • Investigation: Bahk JH.

  • Methodology: Kim YH, Park HY.

  • Writing - original draft: Bahk JH.

  • Writing - review & editing: Ha KY, Bahk JH, Kim SI.

References

1. Lee MJ, Konodi MA, Cizik AM, Bransford RJ, Bellabarba C, Chapman JR. Risk factors for medical complication after spine surgery: a multivariate analysis of 1,591 patients. Spine J. 2012; 12(3):197–206. PMID: 22245448.
crossref
2. Shapiro G, Green DW, Fatica NS, Boachie-Adjei O. Medical complications in scoliosis surgery. Curr Opin Pediatr. 2001; 13(1):36–41. PMID: 11176241.
crossref
3. Baron EM, Albert TJ. Medical complications of surgical treatment of adult spinal deformity and how to avoid them. Spine. 2006; 31(19):Suppl. S106–18. PMID: 16946627.
crossref
4. Sciubba DM, Yurter A, Smith JS, Kelly MP, Scheer JK, Goodwin CR, et al. A comprehensive review of complication rates after surgery for adult deformity: a reference for informed consent. Spine Deform. 2015; 3(6):575–594. PMID: 27927561.
crossref
5. Smith JS, Klineberg E, Lafage V, Shaffrey CI, Schwab F, Lafage R, et al. Prospective multicenter assessment of perioperative and minimum 2-year postoperative complication rates associated with adult spinal deformity surgery. J Neurosurg Spine. 2016; 25(1):1–14. PMID: 26918574.
crossref
6. Althausen PL, Gupta MC, Benson DR, Jones DA. The use of neostigmine to treat postoperative ileus in orthopedic spinal patients. J Spinal Disord. 2001; 14(6):541–545. PMID: 11723407.
crossref
7. Al Maaieh MA, Du JY, Aichmair A, Huang RC, Hughes AP, Cammisa FP, et al. Multivariate analysis on risk factors for postoperative ileus after lateral lumbar interbody fusion. Spine. 2014; 39(8):688–694. PMID: 24480952.
crossref
8. Oh CH, Ji GY, Yoon SH, Hyun D, Park HC, Kim YJ. Paralytic ileus and prophylactic gastrointestinal motility medication after spinal operation. Yonsei Med J. 2015; 56(6):1627–1631. PMID: 26446646.
crossref
9. Ichinose K, Yanagi F, Higashi K, Kozuma S, Akasaka T. Recurrent transient increases in liver enzymes specifically after isoflurane anesthesia. Masui. 1999; 48(4):421–423. PMID: 10339946.
10. Obata R, Bito H, Ohmura M, Moriwaki G, Ikeuchi Y, Katoh T, et al. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function. Anesth Analg. 2000; 91(5):1262–1268. PMID: 11049919.
crossref
11. Ottinger LW. Acute cholecystitis as a postoperative complication. Ann Surg. 1976; 184(2):162–165. PMID: 952563.
crossref
12. Floman Y, Micheli LJ, Barker WD, Hall JE. Acute cholecystitis following the surgical treatment of spinal deformities in the adult: a report of three cases. Clin Orthop Relat Res. 1980; (151):205–209.
13. Rochling FA. Evaluation of abnormal liver tests. Clin Cornerstone. 2001; 3(6):1–12.
crossref
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373–383. PMID: 3558716.
crossref
15. Radovanovic D, Seifert B, Urban P, Eberli FR, Rickli H, Bertel O, AMIS Plus Investigators, et al. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012. Heart. 2014; 100(4):288–294. PMID: 24186563.
crossref
16. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011; 173(6):676–682. PMID: 21330339.
crossref
17. Fineberg SJ, Nandyala SV, Kurd MF, Marquez-Lara A, Noureldin M, Sankaranarayanan S, et al. Incidence and risk factors for postoperative ileus following anterior, posterior, and circumferential lumbar fusion. Spine J. 2014; 14(8):1680–1685. PMID: 24184650.
crossref
18. Asha MJ, Choksey MS, Shad A, Roberts P, Imray C. The role of the vascular surgeon in anterior lumbar spine surgery. Br J Neurosurg. 2012; 26(4):499–503. PMID: 22577849.
crossref
19. Vilz TO, Stoffels B, Strassburg C, Schild HH, Kalff JC. Ileus in adults. Dtsch Arztebl Int. 2017; 114(29-30):508–518. PMID: 28818187.
crossref
20. Ogilvy AJ, Smith G. The gastrointestinal tract after anaesthesia. Eur J Anaesthesiol Suppl. 1995; 10:35–42. PMID: 7641642.
21. Behm B, Stollman N. Postoperative ileus: etiologies and interventions. Clin Gastroenterol Hepatol. 2003; 1(2):71–80. PMID: 15017498.
crossref
22. Artinyan A, Nunoo-Mensah JW, Balasubramaniam S, Gauderman J, Essani R, Gonzalez-Ruiz C, et al. Prolonged postoperative ileus-definition, risk factors, and predictors after surgery. World J Surg. 2008; 32(7):1495–1500. PMID: 18305994.
crossref
23. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 2003; 63(7):649–671. PMID: 12656645.
24. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009; 91(7):1621–1629. PMID: 19571084.
crossref
25. Moghadamyeghaneh Z, Hwang GS, Hanna MH, Phelan M, Carmichael JC, Mills S, et al. Risk factors for prolonged ileus following colon surgery. Surg Endosc. 2016; 30(2):603–609. PMID: 26017914.
crossref
26. Murphy MM, Tevis SE, Kennedy GD. Independent risk factors for prolonged postoperative ileus development. J Surg Res. 2016; 201(2):279–285. PMID: 27020808.
crossref
TOOLS
Similar articles